IL17A and COVID-19: As summarized in (Fig. 8c), in comparison with six controls, a significantly higher amount of CD4+ T cells from eight COVID-19 patients was able to produce TNF, CD107a, IFN-γ, IL-2, and particularly IL-17 (that showed the highest difference).